Advisor Group Holdings, Inc. Nektar Therapeutics Transaction History

Advisor Group Holdings, Inc.

$42.2 Billion
Q3 2024

A detailed history of Advisor Group Holdings, Inc. transactions in Nektar Therapeutics stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 42,067 shares of NKTR stock, worth $39,122. This represents 0.0% of its overall portfolio holdings.

Number of Shares

42,067

Previous 38,730 8.62%

Holding current value

$39,122

Previous $48,000 12.5%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$1.11 - $1.48 $3,704 - $4,938	3,337 Added 8.62%	42,067 $54,000
Q2 2024 Aug 13, 2024	SELL	$0.9 - $1.83 $7,920 - $16,105	-8,801 Reduced 18.52%	38,730 $48,000
Q1 2024 May 10, 2024	BUY	$0.49 - $0.96 $6,737 - $13,200	13,750 Added 40.7%	47,531 $44,000
Q4 2023 Feb 12, 2024	SELL	$0.42 - $0.57 $4,477 - $6,076	-10,660 Reduced 23.99%	33,781 $18,000
Q3 2023 Nov 13, 2023	SELL	$0.51 - $1.05 $1,543 - $3,177	-3,026 Reduced 6.37%	44,441 $26,000
Q2 2023 Aug 10, 2023	BUY	$0.53 - $1.03 $2,118 - $4,116	3,997 Added 9.19%	47,467 $27,000
Q1 2023 May 12, 2023	BUY	$0.64 - $3.15 $1,368 - $6,734	2,138 Added 5.17%	43,470 $30,000
Q4 2022 Feb 10, 2023	SELL	$2.03 - $4.28 $8,992 - $18,960	-4,430 Reduced 9.68%	41,332 $93,000
Q3 2022 Nov 14, 2022	BUY	$3.04 - $5.14 $583 - $986	192 Added 0.42%	45,762 $147,000
Q2 2022 Aug 10, 2022	SELL	$3.17 - $6.17 $2,795 - $5,441	-882 Reduced 1.9%	45,570 $174,000
Q1 2022 May 04, 2022	BUY	$4.16 - $13.72 $78,054 - $257,428	18,763 Added 67.76%	46,452 $3.46 Million
Q3 2021 Nov 05, 2021	SELL	$13.07 - $18.84 $173,425 - $249,987	-13,269 Reduced 32.4%	27,689 $498,000
Q2 2021 Aug 02, 2021	BUY	$16.52 - $20.4 $113,938 - $140,698	6,897 Added 20.25%	40,958 $702,000
Q1 2021 May 13, 2021	SELL	$16.56 - $25.46 $31,232 - $48,017	-1,886 Reduced 5.25%	34,061 $681,000
Q4 2020 Feb 10, 2021	SELL	$15.77 - $19.03 $43,714 - $52,751	-2,772 Reduced 7.16%	35,947 $611,000
Q3 2020 Nov 12, 2020	BUY	$16.59 - $24.79 $67,106 - $100,275	4,045 Added 11.67%	38,719 $645,000
Q2 2020 Aug 14, 2020	SELL	$16.86 - $23.44 $194,244 - $270,052	-11,521 Reduced 24.94%	34,674 $803,000
Q1 2020 May 18, 2020	BUY	$14.47 - $27.96 $668,441 - $1.29 Million	46,195 New	46,195 $809,000

Others Institutions Holding NKTR

# of Institutions

145

Shares Held

139M

Call Options Held

32.6K

Put Options Held

14.1K

View Full List

About NEKTAR THERAPEUTICS

Ticker NKTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,404,992
Market Cap $174M
Description
Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...

More about NKTR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.

Account

Advisor Group Holdings, Inc. Nektar Therapeutics Transaction History